Poseida Therapeutics Inc
(PSTX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 49,340 | 30,545 | 53,297 | 44,472 | 25,503 |
| Marketable Securities | 181,512 | 207,267 | 145,349 | 167,730 | 213,334 |
| Receivables | 14,749 | 12,427 | 12,027 | 9,010 | 8,672 |
| TOTAL | $250,704 | $254,336 | $216,732 | $226,475 | $252,664 |
| Non-Current Assets | |||||
| PPE Net | 17,366 | 17,759 | 18,364 | 19,055 | 20,382 |
| Intangibles | 5,548 | 5,548 | 5,548 | 5,548 | 5,548 |
| Other Non-Current Assets | 19,959 | 21,043 | 21,936 | 22,807 | 23,658 |
| TOTAL | $42,873 | $44,350 | $45,848 | $47,410 | $49,588 |
| Total Assets | $293,577 | $298,686 | $262,580 | $273,885 | $302,252 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,197 | 2,990 | 2,704 | 3,267 | 2,542 |
| Accrued Expenses | 29,714 | 30,116 | 26,294 | 31,092 | 23,715 |
| TOTAL | $78,269 | $102,434 | $84,763 | $71,318 | $76,973 |
| Non-Current Liabilities | |||||
| Long Term Debt | 58,908 | 58,796 | 58,691 | 58,590 | 58,491 |
| Deferred Revenues | 37,273 | 63,289 | 49,770 | 31,008 | 44,810 |
| Other Non-Current Liabilities | 20,787 | 21,715 | 22,629 | 23,496 | 24,341 |
| TOTAL | $128,097 | $135,435 | $93,223 | $98,866 | $101,619 |
| Total Liabilities | $206,366 | $237,869 | $177,986 | $170,184 | $178,592 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 97,465 | 97,120 | 96,958 | 96,489 | 95,624 |
| Common Shares | 10 | 10 | 10 | 10 | 10 |
| Retained earnings | -629,701 | -649,936 | -618,565 | -594,291 | -568,942 |
| Other shareholders' equity | 376 | -82 | -47 | 126 | -200 |
| TOTAL | $87,211 | $60,817 | $84,594 | $103,701 | $123,660 |
| Total Liabilities And Equity | $293,577 | $298,686 | $262,580 | $273,885 | $302,252 |